Event Date
Xiao-Jing Wang, M.D., Ph.D., Stowell Endowed Chair, Department of Pathology and Laboratory Medicine, University of California, Davis, presents "Paradoxical roles of TGFb in diseases and cancer: are they therapeutically targetable?"
Dr. Xiao-Jing Wang received her MD and PhD degrees from Beijing Medical University, the most prestigious medical school in China. She came to the United States for her postdoctoral training at MD Anderson Cancer Center and Baylor College of Medicine in Texas. At Baylor, she rose to the rank to tenured Associate Professor before moving to Oregon Health Science University (OHSU) as Full Professor where she initiated head&neck Cancer Research Program there. In 2008, she was recruited to University of Colorado Anschutz Medical Campus as John Gates Endowed Chair of Cancer Stem Cell Biology and the founding Director of the Head&Neck Cancer Research Program. As a Director and PI, she established a T32 Program in Lung and Head&Neck Cancer (continuously funded for 10 yrs), and a SPORE Program for Head&Neck Cancer (funded in 2021). In 2022, Dr. Wang was recruited to UCDavis as Professor and Stowell Endowed Chair in Pathology and Experimental Medicine in Department of Pathology and Laboratory Medicine. She also serves as Chief Science Officer and Associate Director for Basic Science at UCDavis Comprehensive Cancer Center. Her laboratory has a long history of studying cancer biology, inflammatory skin diseases and wound healing.
Host: Wolf Heyer (wdheyer@ucdavis.edu)